Skip to main content
Quest Diagnostics Home

Dysregulated Erythroid Mg 2+ Efflux in Type 2 Diabetes

Dysregulated Erythroid Mg 2+ Efflux in Type 2 Diabetes

Authors: Ferreira A, Rivera A, Wohlgemuth JG, Dlott JS, Snyder LM, Alper SL, Romero JR.

Front Cell Dev Biol. 2022 Apr 4;10:861644. doi: 10.3389/fcell.2022.861644. eCollection 2022.

Specialties: Cardiology, Endocrinology, Oncology

Our company

Locations Careers Investors Specialty labs Newsroom
Site map   •   Privacy   •   Terms   •   Cookie notice   •   Contact us   •   Language assistance / non-discrimination   •   Asistencia de idiomas / Aviso de no discriminación   •   語言協助 / 不歧視通知   •   Privacy Shield   •   DO NOT SELL MY PERSONAL INFORMATION   •   Accessibility

Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2022 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.